This inventor holds 1 USPTO granted patent. Top assignees: Astellas Pharma Gmbh, Kotobuki Pharmaceutical Co Ltd. Active years: 2012.
Company Filing History:

Years Active: 2012
Title: Kousuke Komenoi: Innovator in C-Glycoside Derivative Production
Introduction
Kousuke Komenoi is a notable inventor based in Chuo-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the production of C-glycoside derivatives. His innovative methods are aimed at improving the efficiency and cost-effectiveness of these compounds, which have important applications in treating diabetes.
Latest Patents
Komenoi holds a patent for a "Method for producing C-glycoside derivative and intermediate for synthesis thereof." This invention provides a method that allows for the production of C-glycoside derivatives at a high yield and low cost. The process aligns with environmental protection standards and is applicable in industrial settings. The C-glycoside derivative produced through this method is particularly useful for treating and preventing various forms of diabetes, including insulin-dependent diabetes (type 1) and non-insulin-dependent diabetes (type 2), as well as related conditions such as insulin resistance and obesity. He has 1 patent to his name.
Career Highlights
Throughout his career, Kousuke Komenoi has worked with prominent companies in the pharmaceutical industry. Notable among these are Kotobuki Pharmaceutical Co., Ltd. and Astellas Pharma GmbH. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Komenoi has collaborated with several professionals in his field, including Masakazu Imamura and Ryota Shiraki. These partnerships have likely enhanced his research and development efforts, leading to advancements in his patented methods.
Conclusion
Kousuke Komenoi is a distinguished inventor whose work in the production of C-glycoside derivatives has the potential to make a significant impact on diabetes treatment. His innovative methods and collaborations reflect his commitment to advancing pharmaceutical science.